Obefazimod Results in Clinical Remission for Majority of Ulcerative Colitis Patients
The results show 52.5% of patients achieved clinical remission at week 96, while 59.0% saw endoscopic improvement, 35.9% achieved endoscopic remission, and 70.5% achieved a clinical response.